Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
CardioVascular and Interventional Radiology
Published in: CardioVascular and Interventional Radiology 4/2019

01-04-2019 | Clinical Investigation

Gastric Embolization as Treatment for Overweight Patients; Efficacy and Safety

Authors: S. Elens, T. Roger, M. Elens, J. Rommens, A. Sarafidis, E. Capelluto, C. Delcour

Published in: CardioVascular and Interventional Radiology | Issue 4/2019

Login to get access

Abstract

Objectives

The aim of this study was to evaluate the efficacy and safety of left gastric artery (LGA) embolization for the treatment of overweight patients who weren’t candidates for bariatric surgery.

Materials and Methods

We retrospectively collected data of 16 patients who underwent a selective embolization of the LGA. The mean body mass index (BMI) before intervention was 28.9 kg/m2 ± 2.5, and therefore, patients were not candidates for bariatric surgery in Belgium. The embolization was realized with 500–700 µm particles via the right common femoral artery approach. Before and following the intervention, an upper endoscopy was performed. Patient demographics, weight loss, hunger sensation and a satisfactory scale were reviewed.

Results

Between February 2015 and May 2017, 16 overweight patients were treated, one embolization was unsuccessful. Four (25%) patients were lost in follow-up. Nine (56%) patients showed early weight loss, one (6%) maintained his bodyweight and one (6%) patient underwent bariatric surgery 2 years after consultation. Only one (6%) patient had a gastric ulceration on control endoscopy. One (6%) patient ended in the intensive care unit for pancreatitis and gastric perforation. The mean weight loss was 8 kg ± 5.12, reducing their mean BMI to 25.5 ± 3.5. The hunger sensation was decreased, and patients were satisfied.

Conclusion

This is a preliminary study in an overweight population that appears to induce weight loss and appetite suppression. Larger studies are needed to confirm these preliminary findings.
Literature
1.
Elder KA, Wolfe BM. Bariatric surgery: a review of procedures and outcomes. Gastroenterology. 2007;132(6):2253–71.CrossRefPubMed
2.
O’Rourke RW, Andrus J, Diggs BS, Scholz M, McConnell DB, Deveney CW. Perioperative morbidity associated with bariatric surgery: an academic center experience. Arch Surg. 2006;141(3):262–8.CrossRefPubMed
3.
Weiss CR, Gunn AJ, Kim CY, Paxton BE, Kraitchman DL, Arepally A. Bariatric embolization of the gastric arteries for the treatment of obesity. J Vasc Interv Radiol. 2015;26:613–24.CrossRefPubMedPubMedCentral
4.
Arepally A, Barnett BP, Montgomery E, Patel TH. Catheter-directed gastric artery chemical embolization for modulation of systemic ghrelin levels in a porcine model: initial experience. Radiology. 2007;244(1):138–43.CrossRefPubMed
5.
Paxton BE, Kim CY, Alley CL, Crow JH, Balmadrid B, Keith CG, Kankotia RJ, Stinnett S, Arepally A. Bariatric embolization for suppression of the hunger hormone ghrelin in a porcine model. Radiology. 2013;266(2):471–9.CrossRefPubMed
6.
Diana M, Pop R, Beaujeux R, Dallemagne B, Halvax P, Schlagowski I, Liu YY, Diemunsch P, Geny B, Lindner V, Marescaux J. Embolization of arterial gastric supply in obesity (EMBARGO): an endovascular approach in the management of morbid obesity. Proof of the concept in the porcine model. Obes Surg. 2015;25(3):550–8.CrossRefPubMed
7.
Syed MI, Morar K, Shaikh A, Craig P, Khan O, Patel S. Khabiri H. Gastric artery embolization trial for the lessening of appetite nonsurgically (GET LEAN): six-Month preliminary data. J Vasc Interv Radiol. 2016;27(10):1502–8.CrossRefPubMed
8.
Kipshidze N, Archvadze A, Bertog S, Leon MB, Sievert H. Endovascular bariatrics: first in humans study of gastric artery embolization for weight loss, JACC. Cardiovasc Interv. 2015;8(12):1641–4.CrossRef
9.
Weiss CR, Akinwande O, Paudel K, Cheskin LJ, Holly B, Hong K, Fischman AM, Patel RS, Shin EJ, Steele KE, Moran TH, Kaiser K, Park A, Shade DM, Kraitchman DL, Arepally A. Clinical safety of bariatric arterial embolization: preliminary results of the BEAT obesity trial. Radiology. 2017;283:160914.CrossRef
10.
Vairavamurthya J, Cheskinb LJ, Kraitchmanc DL, Arepally A, Weiss CR. Current and cutting-edge interventions for the treatment of obese patients. Eur J Radiol. 2017;93:134–42.CrossRef
11.
Kim CY, Paxton BE, Weiss CR, Arepally A. Bariatric embolization for the treatment of obesity. Gastroint Interv. 2014;3(2):80–3.CrossRef
12.
13.
Wadden TA, Butryn ML, Byrne KJ. Efficacy of lifestyle modification for long-term weight control. Obes Res. 2004;12(Suppl):151S–62S.CrossRefPubMed
14.
Metadata
Title
Gastric Embolization as Treatment for Overweight Patients; Efficacy and Safety
Authors
S. Elens
T. Roger
M. Elens
J. Rommens
A. Sarafidis
E. Capelluto
C. Delcour
Publication date
01-04-2019
Publisher
Springer US
Published in
CardioVascular and Interventional Radiology / Issue 4/2019
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-018-2130-x

Other articles of this Issue 4/2019

CardioVascular and Interventional Radiology 4/2019 Go to the issue

Laboratory Investigation

Nuclear Factor-κB is Activated in Filter-Implanted Vena Cava

Clinical Investigation

Minimally Invasive Treatment for Benign Prostatic Hyperplasia: Economic Evaluation from a Standardized Hospital Case Costing System

Letter to the Editor

Vertebral Compression Fracture as the Complication of Embolization by Direct Puncture with Transpedicular Approach in a Patient with Type II Endoleak After Endovascular Aortic Repair

Clinical Investigation

Irreversible Electroporation for Unresectable Hepatocellular Carcinoma: Initial Experience

Case Report

Interventional Management of Subcapsular Hepatic Hematoma with Hepatic Compartment Syndrome After Laparoscopic Adrenalectomy

Correction

Correction to: Minimally Invasive Treatment for Benign Prostatic Hyperplasia: Economic Evaluation from a Standardized Hospital Case Costing System